Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
Most Recent Events
- 26 Sep 2018 Biomarkers information updated
- 15 Aug 2012 Actual patient number changed from 51 to 102 as reported by ClinicalTrials.gov.
- 17 Jan 2010 Planned number of patients changed from 140 to 51 as reported by ClinicalTrials.gov.